Array BioPharma Inc (ARRY)

3.43
0.17 4.72
NASDAQ : Health Care
Prev Close 3.60
Open 3.60
Day Low/High 3.40 / 3.63
52 Wk Low/High 2.38 / 6.04
Volume 2.68M
Avg Volume 2.07M
Exchange NASDAQ
Shares Outstanding 145.02M
Market Cap 498.88M
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Interesting ARRY Put And Call Options For October 21st

Interesting ARRY Put And Call Options For October 21st

Investors in Array BioPharma Inc. saw new options begin trading today, for the October 21st expiration.

Array BioPharma (ARRY) Stock Drops on Failed Lung Cancer Drug Trial

Array BioPharma (ARRY) Stock Drops on Failed Lung Cancer Drug Trial

Array BioPharma (ARRY) stock was tumbling in late-afternoon trading after the company's cancer drug trial failed to meet its primary endpoint.

Array BioPharma (ARRY) Trading With Heavy Volume Before Market Open

Array BioPharma (ARRY) Trading With Heavy Volume Before Market Open

Trade-Ideas LLC identified Array BioPharma (ARRY) as a pre-market mover with heavy volume candidate

5 Best-Positioned Biotech Stocks on Brexit Volatility

5 Best-Positioned Biotech Stocks on Brexit Volatility

Biotech stocks remain pressured following the recent Brexit vote, which will make investing in these already highly volatile stocks even trickier. But there are opportunities too.

Array BioPharma (ARRY) Stock: Weak On High Volume Today

Array BioPharma (ARRY) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Array BioPharma (ARRY) as a weak on high relative volume candidate

First Week of December 16th Options Trading For Array BioPharma (ARRY)

First Week of December 16th Options Trading For Array BioPharma (ARRY)

Investors in Array BioPharma Inc. saw new options begin trading this week, for the December 16th expiration.

Loxo Cancer Drug Targets Gene Mutation With Durable Responses in Early Study

Loxo Cancer Drug Targets Gene Mutation With Durable Responses in Early Study

Six patients, all with TRK fusion cancers unresponsive to current therapies, reported tumor shrinkage following treatment with Loxo's drug LOXO-101.

Array BioPharma (ARRY) Is Today's Strong On High Volume Stock

Array BioPharma (ARRY) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Array BioPharma (ARRY) as a strong on high relative volume candidate

Array BioPharma (ARRY) Is Strong On High Volume Today

Array BioPharma (ARRY) Is Strong On High Volume Today

Trade-Ideas LLC identified Array BioPharma (ARRY) as a strong on high relative volume candidate

Array BioPharma (ARRY) Is Today's Strong On High Volume Stock

Array BioPharma (ARRY) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Array BioPharma (ARRY) as a strong on high relative volume candidate

Commit To Buy Array BioPharma At $2, Earn 25% Using Options

Commit To Buy Array BioPharma At $2, Earn 25% Using Options

Investors eyeing a purchase of Array BioPharma Inc. stock, but tentative about paying the going market price of $3.19/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Short Interest In Array BioPharma Moves 10.3% Lower

Short Interest In Array BioPharma Moves 10.3% Lower

The most recent short interest data has been released by the NASDAQ for the 12/31/2015 settlement date, which shows a 2,674,046 share decrease in total short interest for Array BioPharma Inc. , to 23,339,973, a decrease of 10.28% since 12/15/2015.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

QIAGEN Reaches Milestone With Portfolio Of Master Collaboration Agreements For Pharma Companion Diagnostics

QIAGEN Reaches Milestone With Portfolio Of Master Collaboration Agreements For Pharma Companion Diagnostics

Record number of new projects involves start of new master collaboration with Array BioPharma

Array Biopharma (ARRY) Stock Spikes on Successful Drug Study

Array Biopharma (ARRY) Stock Spikes on Successful Drug Study

Array Biopharma (ARRY) stock is skyrocketing in afternoon trading on Wednesday following a successful late-stage study for its skin cancer drug.

Array BioPharma (ARRY) Moving On Heavy Pre-Market Trading

Array BioPharma (ARRY) Moving On Heavy Pre-Market Trading

Trade-Ideas LLC identified Array BioPharma (ARRY) as a pre-market mover with heavy volume candidate

Array BioPharma (ARRY): Today's Weak On High Volume Stock

Array BioPharma (ARRY): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Array BioPharma (ARRY) as a weak on high relative volume candidate

Array BioPharma (ARRY) Strong On High Relative Volume Today

Array BioPharma (ARRY) Strong On High Relative Volume Today

Trade-Ideas LLC identified Array BioPharma (ARRY) as a strong on high relative volume candidate

Trade-Ideas: Array BioPharma (ARRY) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: Array BioPharma (ARRY) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified Array BioPharma (ARRY) as a weak on high relative volume candidate

Array BioPharma Enters Oversold Territory (ARRY)

Array BioPharma Enters Oversold Territory (ARRY)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of ARRY June 2016 Options Trading

First Week of ARRY June 2016 Options Trading

Investors in Array BioPharma Inc. saw new options begin trading this week, for the June 2016 expiration.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

Array BioPharma Becomes Oversold (ARRY)

Array BioPharma Becomes Oversold (ARRY)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting ARRY Put And Call Options For November 20th

Interesting ARRY Put And Call Options For November 20th

Investors in Array BioPharma Inc. saw new options become available this week, for the November 20th expiration.

Array BioPharma (ARRY) Flagged As Strong On High Volume

Array BioPharma (ARRY) Flagged As Strong On High Volume

Trade-Ideas LLC identified Array BioPharma (ARRY) as a strong on high relative volume candidate